Sponsor:
M.D. Anderson Cancer Center
Code:
NCT04776941
Conditions
Hematopoietic and Lymphoid Cell Neoplasm
Malignant Solid Neoplasm
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Behavioral Intervention
Behavioral Intervention
Behavioral Intervention
Behavioral Intervention
Quality-of-Life Assessment
Brief summary:
Conditions
Hematopoietic and Lymphoid Cell Neoplasm
Malignant Solid Neoplasm
Study ID
NCT04776941
Start date
Aug 7, 2020
Status verified date
Aug, 2026
Completion date
Dec 31, 2028
Anticipated
Primary completion date
Dec 31, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
414 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Supportive Care
Arms
experimental: Arm I (questionnaires, messages, writing)
active comparator: Arm II (questionnaires, messages, writing)
Interventions
Behavioral Intervention
Behavioral Intervention
Behavioral Intervention
Behavioral Intervention
Quality-of-Life Assessment
Questionnaire Administration
Primary outcome measure
Central contacts
Locations
M D Anderson Cancer Center
Recruiting
Houston, Texas, United States, 77030
Contacts
Principal Investigator:
Qian Lu
Sponsor
M.D. Anderson Cancer Center
Last update posted
Aug 14, 2026
Last verified
Aug, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2026-08-14.